Public Profile

Kedrion

Kedrion Biopharma, commonly referred to as Kedrion, is a leading global player in the biopharmaceutical industry, headquartered in Italy. Founded in 2001, the company has established a strong presence in major operational regions, including Europe and North America, focusing on the development and production of human plasma-derived therapies. Kedrion's core offerings include immunoglobulins, clotting factors, and albumin, which are essential for treating various medical conditions. What sets Kedrion apart is its commitment to quality and innovation, ensuring that its products meet the highest safety standards. With a robust market position, Kedrion has achieved significant milestones, including expanding its product portfolio and enhancing its global distribution network, solidifying its reputation as a trusted provider in the biopharmaceutical sector.

DitchCarbon Score

How does Kedrion's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

33

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Kedrion's score of 33 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.

63%

Let us know if this data was useful to you

Kedrion's reported carbon emissions

In 2023, Kedrion reported total carbon emissions of approximately 60,821 kg CO2e, comprising 27,304 kg CO2e from Scope 1 emissions and 33,517 kg CO2e from Scope 2 emissions. This reflects a commitment to monitoring and reducing their carbon footprint, although specific reduction targets have not been disclosed. Over the years, Kedrion's emissions have varied, with notable figures from previous years including 30,122 kg CO2e in 2022, 42,475 kg CO2e in 2021, and 32,736,000 kg CO2e in 2020. The company has consistently reported emissions across Scope 1 and Scope 2, indicating a focus on direct and indirect emissions from their operations. Kedrion has not established specific science-based targets or climate pledges, but their ongoing emissions tracking demonstrates a commitment to transparency and accountability in their climate impact. The company is headquartered in Italy and operates globally, aligning with industry standards for climate reporting.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20162017201820192020202120222023
Scope 1
32,365,000
00,000,000
00,000,000
0,000
00,000,000
00,000
00,000
00,000
Scope 2
18,358,000
00,000,000
00,000,000
00
00
00,000
00,000
00,000
Scope 3
-
-
-
-
-
-
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Kedrion's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Kedrion is in IT, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Kedrion is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Emergent BioSolutions Canada Inc.

CA
Health and social work services (85)
Updated 4 months ago
DitchCarbon Score

Abeona Therapeutics Inc.

US
Health and social work services (85)
Updated 21 days ago

Saol Therapeutics Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

CSL Behring UK Limited

GB
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Cerus Corporation

US
Health and social work services (85)
Updated 21 days ago

ADMA Biologics, Inc.

US
Health and social work services (85)
Updated 21 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers